Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03140488 · ClinicalTrials.gov registry record · Phase 4
Oxytocin Dosage to Decrease Induction Duration
A Phase 4 study, sponsored by University of Arizona.
- Completed
- Registry status
- Phase 4
- Development phase
- 140
- Enrollment target
NCT03140488 is a Phase 4 study that has completed, run by University of Arizona. The registered enrollment target is 140 participants.
The verdict
NCT03140488, a Phase 4 study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 140 participants
- Enrollment target
Study Summary
This is a randomized controlled trial in which women are allocated either 'high dose' or 'low dose' oxytocin infusions for induction of labour. The randomization is stratified by maternal body mass index.
Interventions
- DRUG Oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2017-06-05 |
| Est. Completion | 2019-09-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03140488
The ClinicalTrials.gov registry entry for NCT03140488 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxytocin is the first listed.
NCT03140488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03140488 about?
NCT03140488 is a clinical study titled "Oxytocin Dosage to Decrease Induction Duration". This is a randomized controlled trial in which women are allocated either 'high dose' or 'low dose' oxytocin infusions for induction of labour. The randomization is stratified by maternal body mass index.
What is the current status of trial NCT03140488?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 140 participants. The study started on 2017-06-05. Estimated completion is 2019-09-05.
What interventions are being tested in trial NCT03140488?
The interventions under investigation include: Oxytocin (DRUG).
Who is sponsoring clinical trial NCT03140488?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.